These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7024978)

  • 41. Captopril in the treatment of hypertension.
    Staessen J; Fagard R; Lijnen P; Amery A
    Acta Clin Belg; 1982; 37(3):164-84. PubMed ID: 6214916
    [No Abstract]   [Full Text] [Related]  

  • 42. Discrimination of renovascular from essential hypertension by converting enzyme inhibition with an orally active compound.
    Fagard R; Amery A; Lijnen P; Roussel-Deruyck R
    Acta Clin Belg; 1982; 37(1):13-22. PubMed ID: 7046321
    [No Abstract]   [Full Text] [Related]  

  • 43. Captopril combined with thiazide lowers renin substrate concentration: implications for methodology in renin assays.
    Rasmussen S; Damkjaer Nielsen M; Giese J
    Clin Sci (Lond); 1981 May; 60(5):591-3. PubMed ID: 7018804
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hypotensive and renin-stimulating action of captopril before and during treatment with beta-blockers].
    Bianchini C; Terzoli L; Leonetti G; Banfi E; Castelli D; Zanchetti A
    Cardiologia; 1982; 27(4):381-5. PubMed ID: 6765263
    [No Abstract]   [Full Text] [Related]  

  • 45. Sodium intake and renal responses to captopril in normal man and in essential hypertension.
    Hollenberg NK; Meggs LG; Williams GH; Katz J; Garnic JD; Harrington DP
    Kidney Int; 1981 Aug; 20(2):240-5. PubMed ID: 7026873
    [No Abstract]   [Full Text] [Related]  

  • 46. [Antihypertensive, hemodynamic and endocrine effects of Captopril in arterial hypertension].
    Valvo E; Previato G; Oldrizzi L; Corgnati A; Lupo A; Loschiavo C; Tessitore N; Maschio G
    Minerva Nefrol; 1981; 28(2):139-41. PubMed ID: 7027091
    [No Abstract]   [Full Text] [Related]  

  • 47. [Long-term treatment of severe cardiac failure with captopril (author's transl)].
    Komajda M; Eugène M; Evans J; Lecossier D; Grosgogeat Y
    Nouv Presse Med; 1981 Apr; 10(19):1587-90. PubMed ID: 7025850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Treatment of severe resistant arterial hypertension with captopril. 58 patients, including 38 treated for more than 6 months (author's transl)].
    Zech PY; Trotta P; Labeeuw M
    Nouv Presse Med; 1981 Apr; 10(19):1571-4. PubMed ID: 7025847
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the immediate hemodynamic effects of SQ 14225 (Captopril) and [Sar1, Ileu8] angiotensin II in patients with dialysis resistant hypertension.
    Iseki K; Onoyama K; Fujimi S; Fukiyama K; Omae T
    Clin Nephrol; 1982 Mar; 17(3):149-54. PubMed ID: 7039897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Nifedipine, captopril and nonsteroidal anti-inflammatory agents].
    Salvetti A
    Cardiologia; 1984; 29(9-10):442-3. PubMed ID: 6398707
    [No Abstract]   [Full Text] [Related]  

  • 51. Hypertension in a patient with hypercalcemia: captopril and verapamil.
    Waeber B; Brunner HR; Burckhardt P; Gavras H
    Arch Intern Med; 1982 Jan; 142(1):143-5. PubMed ID: 7032443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Arterial hypertension and oral contraceptives (author's transl)].
    Lekieffre J
    Ann Cardiol Angeiol (Paris); 1979; 28(1):35-9. PubMed ID: 434757
    [No Abstract]   [Full Text] [Related]  

  • 53. [Role of the renin-angiotensin system in the regulation of the vascular resistance of chronic heart failure (author's transl)].
    Noda H; Tokuyasu Y; Takahahashi S; Nakao H; Kimata S; Hirosawa K; Sugino N
    Kokyu To Junkan; 1981 Sep; 29(9):971-6. PubMed ID: 7034102
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effects of angiotensin I converting enzyme inhibitor, captopril, on plasma norepinephrine concentration in hypertensive patients (author's transl)].
    Hirata Y; Takeda T; Murao S; Ishii T; Nishiyama K
    Kokyu To Junkan; 1981 Jul; 29(7):699-702. PubMed ID: 7027386
    [No Abstract]   [Full Text] [Related]  

  • 55. Long-term treatment of childhood hypertension with captopril.
    Oberfield SE; Rapaport R; Levine LS; New MI
    Pediatr Ann; 1982 Jul; 11(7):614-6, 620-1. PubMed ID: 6810289
    [No Abstract]   [Full Text] [Related]  

  • 56. [Combined captopril and labetalol treatment of malignant arterial hypertension (author's transl)].
    El Matri A; Kechrid C; Larabi M; Belkahia C; Ben Ayed H
    Nouv Presse Med; 1981 Apr; 10(19):1575-8. PubMed ID: 7025848
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Evidence for circadian variability in the renin-angiotensin II system (author's transl)].
    G Ital Cardiol; 1974; 4(5):637-40. PubMed ID: 4373301
    [No Abstract]   [Full Text] [Related]  

  • 58. [A reduced aldosterone response to infused angiotensin II in low renin essential hypertension (author's transl)].
    Hidaka H
    Nihon Naika Gakkai Zasshi; 1975 Aug; 64(8):797-808. PubMed ID: 1239475
    [No Abstract]   [Full Text] [Related]  

  • 59. Optimal use and interpretation of the aldosterone renin ratio to detect aldosterone excess in hypertension.
    Doi SA; Abalkhail S; Al-Qudhaiby MM; Al-Humood K; Hafez MF; Al-Shoumer KA
    J Hum Hypertens; 2006 Jul; 20(7):482-9. PubMed ID: 16617310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Usefulness of combined captopril-labetalol treatment in resistant hypertension (author's transl)].
    El Matri A; Larabi MS; Kheder A; Belkahia C; Kechrid C; Ben Maiz H; Ben Ayed H
    Nouv Presse Med; 1982 May; 11(21):1611-3. PubMed ID: 7048251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.